CARDIAC ALLOGRAFT VASCULOPATHY AFTER CARDIAC TRANSPLANTATION

被引：1
|
作者：
WEIS, M
HARTMANN, A
机构：
[1] Abteilung fur Kardiologie, Medizinsche Klinik IV, Universitat Frankfurt, 60590 Frankfurt
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 1995年 / 120卷 / 39期
关键词：
D O I：
10.1055/s-2008-1055482
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1327 / 1333
页数：7
相关论文
共 50 条
  • [31] BENEFIT OF TACROLIMUS/MYCOPHENOLATE TO REDUCE CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION
    Aaronson, Alistair
    Kittleson, Michelle
    Patel, Jignesh
    Rafiei, Matthew
    Osborne, Ashley
    Chang, David
    Czer, Lawrence
    Kobashigawa, Jon
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E798 - E798
  • [32] Cardiac Allograft Vasculopathy and Survival after Heart Transplantation for Chagas' Heart Disease
    Diez, M.
    Favaloro, L.
    Bertolotti, A.
    Vigliano, C.
    Peradejordi, M.
    Schijman, A.
    Favaloro, R.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S32 - S33
  • [33] Effects of Aspirin on Progression of Cardiac Allograft Vasculopathy and Outcomes after Heart Transplantation
    Asleh, R.
    Briasoulis, A.
    Smith, B.
    Lopez, C.
    Lerman, A.
    Pereira, N. L.
    Daly, R. C.
    Kremers, W. K.
    Clavell, A. L.
    Stulak, J. M.
    Kushwaha, S. S.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S76 - S76
  • [34] Identification and Determinants of Cardiac Allograft Vasculopathy Trajectories after Heart Transplantation.
    Bonnet, G.
    Coutance, G.
    Racape, M.
    Raynaud, M.
    Van Keer, J.
    Bories, M.
    Varnous, S.
    Rouvier, P.
    Guillemain, R.
    Lecuyer, L.
    Bruneval, P.
    Duong-Van-Huyen, J.
    Taupin, J.
    Naesens, M.
    Lefaucheur, C.
    Jouven, X.
    Loupy, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 352 - 353
  • [35] Expression of iNOSmRNA to prevent cardiac allograft vasculopathy after heart transplantation in rat
    吴乃石
    藏旺福
    张科峰
    张明宇
    姚志发
    [J]. 外科研究与新技术, 2005, (04) : 293 - 296
  • [36] Validation of the Cardiac Allograft Vasculopathy (CAV) Trajectory Score after Heart Transplantation
    Patel, N.
    Kittleson, M.
    Chang, D.
    Patel, J.
    Azarbal, B.
    Singer-Englar, T.
    Geft, D.
    Czer, L.
    Esmailian, F.
    Kobashigawa, J.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S205 - S205
  • [37] Changes in Myocardial Microvascularisation After Heart Transplantation and During Cardiac Allograft Vasculopathy
    Huibers, M.
    van Pijpen, E.
    Kirkels, H.
    de Jonge, N.
    Vink, A.
    de Weger, R.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S136 - S136
  • [38] Uric Acid is an Independent Predictor of Cardiac Allograft Vasculopathy After Heart Transplantation
    Asleh, Rabea
    Prasad, Megha
    Briasoulis, Alexandros
    Boilson, Barry A.
    Edwards, Brooks S.
    Clavell, Alfredo L.
    Pereira, Naveen L.
    Adigun, Rosalyn
    Simon, Maltais
    Daly, Richard C.
    Lerman, Amir
    Kushwaha, Sudhir S.
    [J]. CIRCULATION, 2017, 136
  • [39] Transforming growth factor β in relation to cardiac allograft vasculopathy after heart transplantation
    Aziz, T
    Hasleton, P
    Hann, AW
    Yonan, N
    Deiraniya, A
    Hutchinson, IV
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2000, 119 (04): : 700 - 707
  • [40] Incidence, progression and functional significance of cardiac allograft vasculopathy after heart transplantation
    Julius, BK
    Jost, CHA
    Sütsch, G
    Brunner, HP
    Kuenzli, A
    Vogt, PR
    Turina, M
    Hess, OM
    Kiowski, W
    [J]. TRANSPLANTATION, 2000, 69 (05) : 847 - 853
12345